- Home
- TLX vs ACLX Comparison
TLX vs ACLX Comparison
Compare TLX & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLX
- ACLX
- Stock Information
- Founded
- TLX 2015
- ACLX 2015
- Country
- TLX Australia
- ACLX United States
- Employees
- TLX N/A
- ACLX N/A
- Industry
- TLX Biotechnology: Pharmaceutical Preparations
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- TLX Health Care
- ACLX Health Care
- Exchange
- TLX Nasdaq
- ACLX Nasdaq
- Market Cap
- TLX 5.0B
- ACLX 5.3B
- IPO Year
- TLX N/A
- ACLX 2022
- Fundamental
- Price
- TLX $16.78
- ACLX $66.48
- Analyst Decision
- TLX Strong Buy
- ACLX Strong Buy
- Analyst Count
- TLX 1
- ACLX 14
- Target Price
- TLX $21.00
- ACLX $107.67
- AVG Volume (30 Days)
- TLX 8.7K
- ACLX 695.1K
- Earning Date
- TLX 01-01-0001
- ACLX 02-26-2025
- Dividend Yield
- TLX N/A
- ACLX N/A
- EPS Growth
- TLX N/A
- ACLX N/A
- EPS
- TLX 0.10
- ACLX N/A
- Revenue
- TLX $430,795,970.00
- ACLX $155,818,000.00
- Revenue This Year
- TLX N/A
- ACLX $12.58
- Revenue Next Year
- TLX N/A
- ACLX N/A
- P/E Ratio
- TLX $168.54
- ACLX N/A
- Revenue Growth
- TLX 80.92
- ACLX 230.33
- 52 Week Low
- TLX $14.01
- ACLX $47.88
- 52 Week High
- TLX $19.99
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- TLX N/A
- ACLX 32.63
- Support Level
- TLX N/A
- ACLX $63.63
- Resistance Level
- TLX N/A
- ACLX $68.24
- Average True Range (ATR)
- TLX 0.00
- ACLX 3.71
- MACD
- TLX 0.00
- ACLX -0.69
- Stochastic Oscillator
- TLX 0.00
- ACLX 16.43
About ACLX Arcellx Inc.
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.